The Enterprise Value as of December 2025 (TTM) for Sionna Therapeutics, Inc. (SION) is 1.79B

According to Sionna Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.79B. This represents a change of 230.25% compared to the average of 542.82M of the last 4 quarters.

Sionna Therapeutics, Inc. (SION) Historical Enterprise Value (quarterly & annually)

How has SION Enterprise Value performed in the past?

The mean historical Enterprise Value of Sionna Therapeutics, Inc. over the last ten years is 1.07B. The current 1.79B Enterprise Value has changed 16.71% with respect to the historical average. Over the past ten years (40 quarters), SION's Enterprise Value was at its highest in in the December 2024 quarter at 1.08B. The Enterprise Value was at its lowest in in the September 2024 quarter at -25754000.00.

Sionna Therapeutics, Inc. (SION) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Sionna Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Sionna Therapeutics, Inc. (SION) Average Enterprise Value

How has SION Enterprise Value performed in the past?

The current Enterprise Value of Sionna Therapeutics, Inc. (SION) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Sionna Therapeutics, Inc. (SION) Enterprise Value vs. Peers

How is SION’s Enterprise Value compared to its peers?

Sionna Therapeutics, Inc.’s Enterprise Value is greater than Janux Therapeutics, Inc. (960.68M), greater than AbCellera Biologics Inc. (1.15B), greater than Maze Therapeutics, Inc. (1.76B), greater than Biohaven Ltd. (1.14B), less than Celldex Therapeutics, Inc. (1.95B), less than Vera Therapeutics, Inc. (2.75B), greater than Xeris Biopharma Holdings, Inc. (1.31B), greater than Zymeworks Inc. (-43935349065.00), greater than Ardelyx, Inc. (1.58B), greater than Immunome, Inc. (1.70B),

Build a custom stock screener for Sionna Therapeutics, Inc. (SION) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sionna Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Sionna Therapeutics, Inc. (SION) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Sionna Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.